A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Clinical trial NCT07033494 · RECRUITING

Trial details

NCT number: NCT07033494
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early Alzheimer's Disease

Start date: 2025-07-16
Primary completion: 2029-04-30
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.